AuthorCitation

Mutation analysis in metastatic colorectal cancers (mCRC) subjected to gene panel testing for BRAF and KRAS genes in clinical practice.

Foster, Nathan R. , Kipp, Benjamin R. , Voss, Jesse S. , Jones, Jeremy C , Sinicrope, Frank A.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15049-e15049

10.1200/jco.2016.34.15_suppl.e15049

Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation.

Benson, Al B. , Meropol, Neal J. , Catalano, Paul J. , Chakravarthy, Bapsi, Flynn, Patrick J. , Catalano, Robert B., Giantonio, Bruce J. , Mitchell, Edith P. , Haller, Daniel G. , Leichman, Cynthia G., Petrelli, Nicholas J. , Tepper, Joel E. , Brierley, James D. , Sigurdson, Elin R., Whittington, Richard M., O’Dwyer, Peter J. , Chakravarthy, A. Bapsi , Zhao, Fengmin , Sinicrope, Frank A. , Whittington, Richard M.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3616-3616

10.1200/jco.2016.34.15_suppl.3616

Clinical outcome of patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) treated with pembrolizumab.

Chakrabarti, Sakti , Mitchelll, Jessica L, Finnes, Heidi D. , Chakrabarti, Sakti , Sinicrope, Frank A. , Eiring, Rachel A. , Hubbard, Joleen M. , McWilliams, Robert R.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e24127-e24127

10.1200/jco.2018.36.15_suppl.e24127

Patterns of palliative care utilization in stage IV non-small cell lung cancer in the National Cancer Database.

Duma, Narjust , Frank, Ryan D. , Yadav, Siddhartha , Molina, Julian R. , Moynihan, Timothy J. , Yadav, Siddhartha , Durani, Urshila , Goyal, Gaurav , Mansfield, Aaron S. , Ailawadhi, Sikander , Go, Ronald S.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10109-10109

10.1200/jco.2018.36.15_suppl.10109

Real-world utilization and patient outcomes associated with pembrolizumab in advanced melanoma in US academic centers and affiliated satellite clinics.

Liu, Frank Xiaoqing, Macahilig, Cynthia, Harshaw, Qing, Shillington, Alicia C. , Joseph, Richard W. , Diede, Scott J. , Dave, Vaidehi

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e21500-e21500

10.1200/jco.2018.36.15_suppl.e21500

Factors predicting the use of immunotherapy for patients with advanced melanoma.

Shillington, Alicia C. , Macahilig, Cynthia, Harshaw, Qing, Liu, Frank Xiaoqing, Joseph, Richard W. , Diede, Scott J. , Dave, Vaidehi

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9571-9571

10.1200/jco.2018.36.15_suppl.9571

Safety and clinical activity of durvalumab in combination with tremelimumab in extensive disease small-cell lung cancer (ED-SCLC).

Cho, Daniel C. , Dowlati, Afshin , Chung, Ki Y. , Schneider, Bryan J. , Razak, Albiruni Ryan Abdul, Tsai, Frank , Balmanoukian, Ani Sarkis, Xiao, Feng , Angra, Natasha, Abdullah, Shaad E. , Mahipal, Amit , Chow, Warren , Segal, Neil Howard , Nemunaitis, John , Bazhenova, Lyudmila , Luke, Jason J.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8517-8517

10.1200/jco.2018.36.15_suppl.8517

Real world outcomes of metastatic pancreatic cancer (mPC) patients (pts) treated with liposomal irinotecan (nal-IRI) in the US.

Surinach, Andy , Corvino, Frank A., Torres, Aracelis Z. , Mamlouk, Khalid, Pulgar, Sonia, Barzi, Afsaneh , Miksad, Rebecca Anne , Wang, Siqi , Bekaii‐Saab, Tanios

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e16229-e16229

10.1200/jco.2018.36.15_suppl.e16229

Validation of tumor infiltrating lymphocytes (TIL) and tumor budding as predictors of prognosis in patients with stage III colon cancers treated in a FOLFOX-based adjuvant trial: NCCTG N0147 (Alliance).

Lee, Hee Eun , Foster, Nathan R. , Smyrk, Thomas C. , Sinicrope, Frank A. , Shi, Qian , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3583-3583

10.1200/jco.2018.36.15_suppl.3583

Phase I trial of z-endoxifen with estrogen receptor imaging in adults with advanced hormone receptor–positive solid tumors including desmoid and gynecologic tumors.

Takebe, Naoko , Harris, Lyndsay N. , Juwara, Lamin, Quinn, Mary Flanagan, Moore, Nancy, Mena, Esther , Lindenberg, Liza , Lin, Frank I. , McGovern, Renee M., Streicher, Howard , Covey, Joseph M. , Collins, Jerry M. , Doroshow, James H. , Chen, Alice P. , O'Sullivan Coyne, Geraldine , Kummar, Shivaani , Reid, Joel M. , Piekarz, Richard , Juwara, Lamin, Choyke, Peter L. , Goetz, Matthew P.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 2516-2516

10.1200/jco.2018.36.15_suppl.2516

Citations

Mutation analysis in metastatic colorectal cancers (mCRC) subjected to gene panel testing for BRAF and KRAS genes in clinical practice.

Foster, Nathan R. , Kipp, Benjamin R. , Voss, Jesse S. , Jones, Jeremy C , Sinicrope, Frank A.

Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation.

Clinical outcome of patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) treated with pembrolizumab.

Chakrabarti, Sakti , Mitchelll, Jessica L, Finnes, Heidi D. , Chakrabarti, Sakti , Sinicrope, Frank A. , Eiring, Rachel A. , Hubbard, Joleen M. , McWilliams, Robert R.

Patterns of palliative care utilization in stage IV non-small cell lung cancer in the National Cancer Database.

Duma, Narjust , Frank, Ryan D. , Yadav, Siddhartha , Molina, Julian R. , Moynihan, Timothy J. , Yadav, Siddhartha , Durani, Urshila , Goyal, Gaurav , Mansfield, Aaron S. , Ailawadhi, Sikander , Go, Ronald S.

Real-world utilization and patient outcomes associated with pembrolizumab in advanced melanoma in US academic centers and affiliated satellite clinics.

Liu, Frank Xiaoqing, Macahilig, Cynthia, Harshaw, Qing, Shillington, Alicia C. , Joseph, Richard W. , Diede, Scott J. , Dave, Vaidehi

Factors predicting the use of immunotherapy for patients with advanced melanoma.

Shillington, Alicia C. , Macahilig, Cynthia, Harshaw, Qing, Liu, Frank Xiaoqing, Joseph, Richard W. , Diede, Scott J. , Dave, Vaidehi

Safety and clinical activity of durvalumab in combination with tremelimumab in extensive disease small-cell lung cancer (ED-SCLC).

Cho, Daniel C. , Dowlati, Afshin , Chung, Ki Y. , Schneider, Bryan J. , Razak, Albiruni Ryan Abdul, Tsai, Frank , Balmanoukian, Ani Sarkis, Xiao, Feng , Angra, Natasha, Abdullah, Shaad E. , Mahipal, Amit , Chow, Warren , Segal, Neil Howard , Nemunaitis, John , Bazhenova, Lyudmila , Luke, Jason J.

Real world outcomes of metastatic pancreatic cancer (mPC) patients (pts) treated with liposomal irinotecan (nal-IRI) in the US.

Surinach, Andy , Corvino, Frank A., Torres, Aracelis Z. , Mamlouk, Khalid, Pulgar, Sonia, Barzi, Afsaneh , Miksad, Rebecca Anne , Wang, Siqi , Bekaii‐Saab, Tanios

Validation of tumor infiltrating lymphocytes (TIL) and tumor budding as predictors of prognosis in patients with stage III colon cancers treated in a FOLFOX-based adjuvant trial: NCCTG N0147 (Alliance).

Lee, Hee Eun , Foster, Nathan R. , Smyrk, Thomas C. , Sinicrope, Frank A. , Shi, Qian , Alberts, Steven R.

Phase I trial of z-endoxifen with estrogen receptor imaging in adults with advanced hormone receptor–positive solid tumors including desmoid and gynecologic tumors.